Low incidence of colorectal dysplasia and cancer among patients with ulcerative colitis: A Turkish referral centre study

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 4, 2010, Pages 434-439

  Kekilli, Murat ^a   Dagli, Ulku ^a   Kalkan, Ismail Hakki ^a   Tunc, Bilge ^a   Disibeyaz, Selcuk ^a   Ulker, Aysel ^a   Sahin, Burhan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Adenomatous polyp; Colon cancer; Colorectal dysplasia; Ulcerative colitis

Indexed keywords

GLUCOCORTICOID; MESALAZINE; STEROID;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER DIAGNOSIS; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL DYSPLASIA; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; TURKEY (REPUBLIC); ULCERATIVE COLITIS;

ADULT; ANALYSIS OF VARIANCE; BIOPSY; COLITIS, ULCERATIVE; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 77949894022     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903540830     Document Type: Article

References (29)

1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5-36
2. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IV: Carcinoma of the colon. Gut 1964;5:15-22
3. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356-1362
4. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis: fact or fiction? Gut 1997;41:522-525
5. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;323:1228-1233
6. Rutter M, Saunders B, Wilkinson K. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-459
7. Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001;120:841-847
8. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study. Gastroenterology 1994;107: 117-120
9. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535
10. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-1451
11. Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes causes and management strategies. World J Gastroenterol 2008;14:3937-3947
12. Winther KV, Jess T, Langholz E, Munkholm P, Binder V. Long-term risk of cancer in ulcerative colitis: a population based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1088-1095
13. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287: G7-17
14. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311-1319
15. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-1648
16. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2004;99:1371-1385
17. Brostrom O, Lofberg R, Nordenvall B, Ost A,Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol 1987;22:1193-1199
18. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut 1988;29:206-217
19. Lashner BA, Provencher KS, Bozdech JM, Brzezinski A. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am J Gastroenterol 1995;90:377-380
20. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population- based study. Cancer 2001;91:854-862
21. Palli D, Trallori G, Bagnoli S, Saieva C, Tarantino O, Ceroti M, et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000;119:647-653
22. Warwick R.R.G, Sumerling M.D, Gilmour H.H. Colonoscopy and double contrast barium enema examination in chronic ulcerative colitis. Am J Rad Ther Nucl Med 1973;117:292-296
23. Rutgeerts P, Vantrappen G, and Geboes K. Endoscopy in inflammatory bowel disease. Scand J Gastroenterol 1988; 24 (suppl 170):12-15
24. Brenna E, Skreden K, Waldum H.L, Mårvik R, Dybdahl JH, Kleveland PM, et al. The benefit of colonoscopy. Scand J Gastroenterol 1990;25:81-88
25. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005;100:1345-1353
26. Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996;110:432-440
27. Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89-95
28. Lindberg J, Stenling R, Palmqvist R, Rutegard J. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years' experience in a patient cohort from a defined population area. Scand J Gastroenterol 2005;40:1076-1080
29. Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006;12:669-676